অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid; sodium chloride - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

e-house korea holdings international - starch, corn (unii: o8232ny3sj) (starch, corn - unii:o8232ny3sj) - starch, corn 3.16 g in 4 g

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - ct943 - instrument/analyser ivds - instrument/analyser ivds

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

lofarma - mustard allergen extract - solution for skin-prick test

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

inmunotek - mustard allergen extract - solution for skin-prick test

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

novartis pharmaceuticals corporation - nateglinide (unii: 41x3pwk4o2) (nateglinide - unii:41x3pwk4o2) - nateglinide 60 mg - starlix is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. limitations of use: starlix should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. starlix is contraindicated in patients with a history of hypersensitivity to starlix or its inactive ingredients. risk summary the available data from published literature and the applicant’s pharmacovigilance with use of starlix in pregnant women are insufficient to identify a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. there are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy (see clinical considerations ). starlix should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. in animal reproduction studies, there was no teratogenicity in rats and rabbits administered oral nateglinide during organogenesis at approxi

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

bryant ranch prepack - norgestimate (unii: c291hfx4dy) (norgestimate - unii:c291hfx4dy), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - estarylla™ (norgestimate and ethinyl estradiol tablets) are indicated for use by females of reproductive potential to prevent pregnancy [see clinical studies (14)] . estarylla™ is contraindicated in females who are known to have or develop the following conditions: - use of hepatitis c drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, due to the potential for alt elevations [seewarnings and precautions (5.3)] there is little or no increased risk of birth defects in women who inadvertently use cocs during early pregnancy. epidemiologic studies and meta-analyses have not found an increased risk of genital or non-genital birth defects (including cardiac anomalies and limb reduction defects) following exposure to low dose cocs prior to conception or during early pregnancy. do not administer cocs to induce withdrawal bleeding as a test for pregnancy. do not use cocs during pregnancy to treat threatened or habitual abortion. advise the nursing mother to use other forms of contraception, when possible, until she has weaned her child. cocs can reduce milk production in breastfeeding mothers. this is less likely to occur once breastfeeding is well-established; however, it can occur at any time in some women. small amounts of oral contraceptive steroids and/or metabolites are present in breast milk. safety and efficacy of norgestimate and ethinyl estradiol tablets have been established in women of reproductive age. efficacy is expected to be the same for post-pubertal adolescents under the age of 18 and for users 18 years and older. use of this product before menarche is not indicated. norgestimate and ethinyl estradiol have not been studied in postmenopausal women and are not indicated in this population. the pharmacokinetics of norgestimate and ethinyl estradiol has not been studied in subjects with hepatic impairment. however, steroid hormones may be poorly metabolized in patients with hepatic impairment. acute or chronic disturbances of liver function may necessitate the discontinuation of coc use until markers of liver function return to normal and coc causation has been excluded. [see contraindications (4) and warnings and precautions ( 5.2).] the pharmacokinetics of norgestimate and ethinyl estradiol has not been studied in women with renal impairment.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

vyaire medical pty ltd - 35467 - analyser, gas, carbon monoxide - a device intended to measure the concentration of carbon monoxide in a gas mixture to assist in the evaluation of metabolic or respiratory status. this device may uses electrochemical analyses techniques.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - ct943 - instrument/analyser ivds - manual, semi-automated or automated instruments/analysers for processing, examining and/or providing information about a clinical specimen.